| Application no. and date | 00974667.8 (espacenet) (Federated) (European Patent Register), 20001101 | | Patent/reg. no. and date | DK/EP 1244647, 20060621 | | Publication date | 20021002 | | Priority no. and date | EP 99402759, 19991105, EP 99402877, 19991119 | | EP pub. no. and date |
EP 1244647 20021002 | | Effective date | | | Applicant/owner | Genzyme Corporation, 500 Kendall Street
Cambridge MA 02142, US | | Applicant ref. no. | AST Z70612 | | Inventor | Stokes, Elaine Sophie Elizabeth, Mereside,
Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
Thomas, Andrew Peter, Mereside,
Alderley Park
Macclesfield,
Cheshire SK10 4TG, GB,
Hennequin, Laurent François André, Z.I. La Pompelle,
Boîte postale 1050
51689 Reims Cedex 2, FR | | Representative | | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , A61P 9/00 (2006.01) , C07D 401/12 (2006.01) | | Title | Quinzolinderivater som VIGF-inhibitorer | | Int. application no. | GB2000004181 | | Int. publication no. | WO2001032651 | | Related patent (certificate) | CA 2012 00032 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
